183
Views
25
CrossRef citations to date
0
Altmetric
Reviews

The cardiovascular safety of rosiglitazone

&
Pages 367-376 | Published online: 10 Jul 2008

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Melissa A. Davidson, Donald R. Mattison, Laurent Azoulay & Daniel Krewski. (2018) Thiazolidinedione drugs in the treatment of type 2 diabetes mellitus: past, present and future. Critical Reviews in Toxicology 48:1, pages 52-108.
Read now

Articles from other publishers (24)

L. Oyejide, O.R. Mendes & I. Mikaelian. 2017. A Comprehensive Guide to Toxicology in Nonclinical Drug Development. A Comprehensive Guide to Toxicology in Nonclinical Drug Development 407 445 .
Philippe Huot, Tom H. Johnston, Susan H. Fox & Jonathan M. Brotchie. (2015) Pioglitazone may impair L-DOPA anti-parkinsonian efficacy in the MPTP-lesioned macaque: Results of a pilot study. Synapse 69:3, pages 99-102.
Crossref
Khodor Abou Daya, Hussein Abu Daya, Mohamad Nasser Eddine, Georges Nahhas & Nuha Nuwayri‐Salti. (2014) Effects of rosiglitazone ( PPAR   γ agonist) on the myocardium in non‐hypertensive diabetic rats 罗格列酮(PPAR γ 激动剂)对非高血压糖尿病大鼠的心肌的影响 . Journal of Diabetes 7:1, pages 85-94.
Crossref
Bin Chen, Huijun Wang, Ying Ding & David Wild. 2015. Semantic Breakthrough in Drug Discovery. Semantic Breakthrough in Drug Discovery.
Paul Paolini, Daniel Pick, Jennifer Lapira, Giuseppina Sannino, Lorenza Pasqualini, Colleen Ludka, L James Sprague, Xian Zhang, Elesha A Bartolotta, Esteban Vazquez-Hidalgo, David Torres Barba, Carlos Bazan & Gary Hardiman. (2014) Developmental and extracellular matrix-remodeling processes in rosiglitazone-exposed neonatal rat cardiomyocytes. Pharmacogenomics 15:6, pages 759-774.
Crossref
Hayley Patricia Ellis & Kathreena Mary Kurian. (2014) Biological Rationale for the Use of PPARγ Agonists in Glioblastoma. Frontiers in Oncology 4.
Crossref
Vaibhavkumar A. Jagtap, G. Vidyasagar & S. C. Dvivedi. (2014) Solubility enhancement of rosiglitazone by using melt sonocrystallization technique. Journal of Ultrasound 17:1, pages 27-32.
Crossref
Ge Xu, Binhua Lv, Jacques Y. Roberge, Baihua Xu, Jiyan Du, Jiajia Dong, Yuanwei Chen, Kun Peng, Lili Zhang, Xinxing Tang, Yan Feng, Min Xu, Wei Fu, Wenbin Zhang, Liangcheng Zhu, Zhongping Deng, Zelin Sheng, Ajith Welihinda & Xun Sun. (2014) Design, Synthesis, and Biological Evaluation of Deuterated C -Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes . Journal of Medicinal Chemistry 57:4, pages 1236-1251.
Crossref
Madona Azar, Timothy J. Lyons, Petar Alaupovic, Julie A. Stoner, Carmen Quiroga, Derrick G. Kaufman, Maria Lopes-Virella, Richard L. Klein & Alicia J. Jenkins. (2013) Apolipoprotein-defined and NMR lipoprotein subclasses in the Veterans Affairs Diabetes Trial. Journal of Diabetes and its Complications 27:6, pages 627-632.
Crossref
Lekan Oyejide, Odete R. Mendes & Igor Mikaelian. 2013. A Comprehensive Guide to Toxicology in Preclinical Drug Development. A Comprehensive Guide to Toxicology in Preclinical Drug Development 237 276 .
Bin Chen, Ying Ding & David J Wild. (2012) Improving integrative searching of systems chemical biology data using semantic annotation. Journal of Cheminformatics 4:1.
Crossref
Alexander R. Ochman, Christopher A. Lipinski, Jeffrey A. Handler, Andrew G. Reaume & Michael S. Saporito. (2012) The Lyn Kinase Activator MLR-1023 Is a Novel Insulin Receptor Potentiator that Elicits a Rapid-Onset and Durable Improvement in Glucose Homeostasis in Animal Models of Type 2 Diabetes. Journal of Pharmacology and Experimental Therapeutics 342:1, pages 23-32.
Crossref
J Davidson, D Rotondo, MT Rizzo & HA Leaver. (2012) Therapeutic implications of disorders of cell death signalling: membranes, micro-environment, and eicosanoid and docosanoid metabolism. British Journal of Pharmacology 166:4, pages 1193-1210.
Crossref
I. Mikaelian, A. Buness, G. Hirkaler, R. Fernandes, D. Coluccio, W. Geng, T. Visalli, M.O. Bachynsky, W. Berkofsky-Fessler, C. Kanwal, H. Hilton, R. Nicklaus, J.-C. Hoflack, M. Dunn, M. Sanders, M. Giron, B.W. Boyle, T. Singer & L. Suter Dick. (2011) Serum cardiac troponin I concentrations transiently increase in rats given rosiglitazone. Toxicology Letters 201:2, pages 110-115.
Crossref
Ji-Yin Zhou & Shi-Wen Zhou. (2011) Protective effect of berberine on antioxidant enzymes and positive transcription elongation factor b expression in diabetic rat liver. Fitoterapia 82:2, pages 184-189.
Crossref
Anna R. Carta, Augusta Pisanu & Ezio Carboni. (2011) Do PPAR-Gamma Agonists Have a Future in Parkinson's Disease Therapy?. Parkinson's Disease 2011, pages 1-14.
Crossref
Fwu-Lin Yang, Yi-Maun Subeq, Chung-Jen Lee, Ru-Ping Lee, Tai-Chu Peng, Horng-Jyh Harn & Bang-Gee Hsu. (2011) Rosiglitazone protects against severe hemorrhagic shock-induced organ damage in rats. Medical Science Monitor 17:10, pages BR282-BR289.
Crossref
Nikolaos P.E. Kadoglou, Hercules Tsanikidis, Alkistis Kapelouzou, Ioannis Vrabas, Ioulia Vitta, Panayotis E. Karayannacos, Christos D. Liapis & Nikolaos Sailer. (2010) Effects of rosiglitazone and metformin treatment on apelin, visfatin, and ghrelin levels in patients with type 2 diabetes mellitus. Metabolism 59:3, pages 373-379.
Crossref
Dirk Sander & Mark T. Kearney. (2009) Reducing the risk of stroke in type 2 diabetes: pathophysiological and therapeutic perspectives. Journal of Neurology 256:10, pages 1603-1619.
Crossref
Steven E. Shoelson. 2001. Kirk-Othmer Encyclopedia of Chemical Technology. Kirk-Othmer Encyclopedia of Chemical Technology 1 18 .
Ying Liu, Simon Chewchuk, Charles Lavigne, Sophie Brûlé, Genevieve Pilon, Vanessa Houde, Aimin Xu, Andre Marette & Gary Sweeney. (2009) Functional significance of skeletal muscle adiponectin production, changes in animal models of obesity and diabetes, and regulation by rosiglitazone treatment. American Journal of Physiology-Endocrinology and Metabolism 297:3, pages E657-E664.
Crossref
Marc Issandou, Anne Bouillot, Jean-Marie Brusq, Marie-Claire Forest, Didier Grillot, Raphaelle Guillard, Sandrine Martin, Christelle Michiels, Thierry Sulpice & Alain Daugan. (2009) Pharmacological inhibition of Stearoyl-CoA Desaturase 1 improves insulin sensitivity in insulin-resistant rat models. European Journal of Pharmacology 618:1-3, pages 28-36.
Crossref
Rainer Breitling. (2009) Robust signaling networks of the adipose secretome. Trends in Endocrinology & Metabolism 20:1, pages 1-7.
Crossref
Jennifer L. Hatton & Lisa D. Yee. (2008) Clinical Use of PPAR Ligands in Cancer . PPAR Research 2008, pages 1-13.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.